{"product_id":"robinsons-current-therapy-in-equine-medicine-7th-edition","title":"Robinsons Current Therapy In Equine Medicine 7Th Edition","description":"\u003cp\u003eRobinsons Current Therapy In Equine Medicine 7Th Edition | Categories: Animals Books \u0026gt; Equine \u0026gt; Robinson’s Current Therapy in Equine Medicine 7th Edition\u003c\/p\u003e\u003cp\u003eDigital veterinary textbook. Instant download after purchase.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSave 20% — Limited time offer!\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eTable of Contents\u003c\/h3\u003e\n\u003cdiv class=\"gvc-locked-preview\"\u003e\n  \u003cdiv class=\"gvc-locked-icon\"\u003e🔒\u003c\/div\u003e\n  \u003ch3\u003eSample Preview\u003c\/h3\u003e\n  \u003cp\u003eThe full PDF is available after purchase. Instant download. Lifetime access. Read on any device.\u003c\/p\u003e\n  \u003cp class=\"gvc-locked-meta\"\u003eTrusted by 4,000+ veterinary professionals worldwide.\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cul\u003e\n  \u003cli\u003ePreface (p.5)\u003c\/li\u003e\n  \u003cli\u003eContents (p.7)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.11)\u003c\/li\u003e\n  \u003cli\u003e2 Ontogeny of Fish Immune System (p.11)\u003c\/li\u003e\n  \u003cli\u003e3 Innate Immune System (p.12)\u003c\/li\u003e\n  \u003cli\u003e4 Adaptive Immune System (p.17)\u003c\/li\u003e\n  \u003cli\u003e5 Factors Affecting the Immune Response (p.20)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.22)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.27)\u003c\/li\u003e\n  \u003cli\u003e2 Nature of Immune Responses (p.27)\u003c\/li\u003e\n  \u003cli\u003e3 Pathogen Recognition and Signalling Pathways (p.39)\u003c\/li\u003e\n  \u003cli\u003e4 Existence of Adaptive-Like Immunity in Crustaceans (p.41)\u003c\/li\u003e\n  \u003cli\u003e5 Summary (p.43)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.44)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.54)\u003c\/li\u003e\n  \u003cli\u003e2 What Is a Vaccine? (p.54)\u003c\/li\u003e\n  \u003cli\u003e3 Properties of Vaccine (p.54)\u003c\/li\u003e\n  \u003cli\u003e4 Types of Vaccine (p.55)\u003c\/li\u003e\n  \u003cli\u003e5 Conclusion (p.63)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.66)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.72)\u003c\/li\u003e\n  \u003cli\u003e2 Status of Vaccine Development for Major Bacterial Diseases of Fish (p.74)\u003c\/li\u003e\n  \u003cli\u003e3 Polyvalent Vaccines (p.84)\u003c\/li\u003e\n  \u003cli\u003e4 Conclusions (p.84)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.91)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.103)\u003c\/li\u003e\n  \u003cli\u003e2 History of Fish Vaccination (p.103)\u003c\/li\u003e\n  \u003cli\u003e3 Viral Diseases and Vaccines for Farmed Finfish (p.104)\u003c\/li\u003e\n  \u003cli\u003e4 Immune Response to Vaccines (p.120)\u003c\/li\u003e\n  \u003cli\u003e5 Concluding Remarks and Future Outlook (p.121)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.121)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.131)\u003c\/li\u003e\n  \u003cli\u003e2 Anti-Parasitic Drugs and Disease Resistance (p.133)\u003c\/li\u003e\n  \u003cli\u003e3 Immune Memory in Fish: The Foundation of Vaccination (p.133)\u003c\/li\u003e\n  \u003cli\u003e4 Challenges in Parasite Vaccine Developments (p.155)\u003c\/li\u003e\n  \u003cli\u003e5 Conclusion (p.155)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.156)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.165)\u003c\/li\u003e\n  \u003cli\u003e2 Oral Vaccines (p.165)\u003c\/li\u003e\n  \u003cli\u003e3 Biofilm of a Bacterial Pathogen as a Novel Oral Vaccine (p.166)\u003c\/li\u003e\n  \u003cli\u003e4 Antigen Expression in Biofilm (p.167)\u003c\/li\u003e\n  \u003cli\u003e5 Gut Mucosal Immunity with Biofilm Oral Vaccine (p.167)\u003c\/li\u003e\n  \u003cli\u003e6 Biofilm as Immunostimulant in Shrimp (p.167)\u003c\/li\u003e\n  \u003cli\u003e7 Bacterial Biofilm as a Carrier of Subunit Vaccine (p.168)\u003c\/li\u003e\n  \u003cli\u003e8 Conclusion (p.168)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.169)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.172)\u003c\/li\u003e\n  \u003cli\u003e2 Principle of RNA Interference (p.173)\u003c\/li\u003e\n  \u003cli\u003e3 Critical Features of RNAi-Based Vaccines (p.175)\u003c\/li\u003e\n  \u003cli\u003e4 Plasmid Vectors for RNAi-Based Vaccines (p.177)\u003c\/li\u003e\n  \u003cli\u003e5 Tissue Distribution and Persistence of Plasmid Constructs (p.178)\u003c\/li\u003e\n  \u003cli\u003e6 Concerns Associated with RNAi Vaccines (p.178)\u003c\/li\u003e\n  \u003cli\u003e7 Routes of Delivery (p.178)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.180)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.186)\u003c\/li\u003e\n  \u003cli\u003e2 Vaccination Trials Against Viruses (p.187)\u003c\/li\u003e\n  \u003cli\u003e3 Vaccination Trials Against Bacterial Diseases in Shrimps (p.202)\u003c\/li\u003e\n  \u003cli\u003e4 Factors Affecting the Efficacy of Vaccination (p.209)\u003c\/li\u003e\n  \u003cli\u003e5 Mechanism of Vaccination in Crustaceans (p.210)\u003c\/li\u003e\n  \u003cli\u003e6 Summary (p.211)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.212)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.222)\u003c\/li\u003e\n  \u003cli\u003e2 Injection Vaccination (p.222)\u003c\/li\u003e\n  \u003cli\u003e3 Immersion Vaccination (p.225)\u003c\/li\u003e\n  \u003cli\u003e4 Oral Vaccination (p.228)\u003c\/li\u003e\n  \u003cli\u003e5 Anal Intubation (p.229)\u003c\/li\u003e\n  \u003cli\u003e6 Intranasal Vaccination (p.230)\u003c\/li\u003e\n  \u003cli\u003e7 Nanoparticle-Based Fish Vaccine Delivery (p.231)\u003c\/li\u003e\n  \u003cli\u003e8 Summary (p.232)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.232)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.236)\u003c\/li\u003e\n  \u003cli\u003e2 Adjuvants (p.236)\u003c\/li\u003e\n  \u003cli\u003e3 Conclusion (p.245)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.246)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.250)\u003c\/li\u003e\n  \u003cli\u003e2 Major Functional Groups of PRRs in Vertebrates with Emphasis on Teleosts (p.251)\u003c\/li\u003e\n  \u003cli\u003e3 Fish Interferons (p.255)\u003c\/li\u003e\n  \u003cli\u003e4 PRR-Mediated Type I IFN Response in Fish (p.256)\u003c\/li\u003e\n  \u003cli\u003e5 PRR Agonists as Adjuvants in Vaccination (p.259)\u003c\/li\u003e\n  \u003cli\u003e6 Fish Type I IFNs as Adjuvant in Vaccination (p.260)\u003c\/li\u003e\n  \u003cli\u003e7 Conclusion (p.261)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.261)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.267)\u003c\/li\u003e\n  \u003cli\u003e2 Calculating Relative Percent Survival (RPS) (p.268)\u003c\/li\u003e\n  \u003cli\u003e3 Measuring Specific Antibody Level as a Correlate of Protection (p.269)\u003c\/li\u003e\n  \u003cli\u003e4 Indirect ELISA for Estimating Antibody Levels (p.270)\u003c\/li\u003e\n  \u003cli\u003e5 Measuring Antigen Dose as Correlate of Protective Immunity (p.270)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.270)\u003c\/li\u003e\n  \u003cli\u003e1 Biosafety in Aquaculture (p.272)\u003c\/li\u003e\n  \u003cli\u003e2 Some Common Terms (p.273)\u003c\/li\u003e\n  \u003cli\u003e3 Committees Involved in Biosafety (p.274)\u003c\/li\u003e\n  \u003cli\u003e4 Classification of Biosafety Levels and Risk Groups (p.275)\u003c\/li\u003e\n  \u003cli\u003e5 Biosafety Requirements for Vaccines (p.276)\u003c\/li\u003e\n  \u003cli\u003e6 Autogenous Vaccines and Regulatory Issues (p.277)\u003c\/li\u003e\n  \u003cli\u003e7 Regulatory Requirements for Licensing of Vaccines (p.278)\u003c\/li\u003e\n  \u003cli\u003e8 Operator Safety During Injection Vaccination of Fish (p.279)\u003c\/li\u003e\n  \u003cli\u003e9 Conclusion (p.280)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.280)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.283)\u003c\/li\u003e\n  \u003cli\u003e2 Adverse Effects of Different Types of Fish Vaccines (p.284)\u003c\/li\u003e\n  \u003cli\u003e3 Adverse Effects of Different Vaccination Methods (p.286)\u003c\/li\u003e\n  \u003cli\u003e4 Risks to Fish Farmers and Consumers (p.289)\u003c\/li\u003e\n  \u003cli\u003e5 Vaccine Failures (p.289)\u003c\/li\u003e\n  \u003cli\u003e6 Measures to Reduce the Adverse Effects (p.290)\u003c\/li\u003e\n  \u003cli\u003e7 Future Perspective (p.290)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.291)\u003c\/li\u003e\n  \u003cli\u003e\u003cem\u003e... and 29 more chapters\u003c\/em\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003cdiv style=\"margin:20px 0;\"\u003e\n\u003ch3\u003ePreview This Book (First 20 Pages)\u003c\/h3\u003e\n\n\u003cp style=\"font-size:12px;color:#666;margin-top:4px;\"\u003eScroll through the preview above to see the first 20 pages of this book.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e🔗 Download Link:\u003c\/strong\u003e \u003c\/p\u003e","brand":"Global Vet \u0026 Co","offers":[{"title":"Default Title","offer_id":51226994311483,"sku":null,"price":210.0,"currency_code":"HKD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0948\/3062\/5083\/files\/robinsons-current-therapy-in-equine-medicine-7th-edition_HD.png?v=1780500768","url":"https:\/\/globalvetco.com\/products\/robinsons-current-therapy-in-equine-medicine-7th-edition","provider":"Global Vet \u0026 Co Ltd","version":"1.0","type":"link"}